Asabys | search
Click here to view Asabys news from 60+ newspapers.
Bookmark or Share- Sabadell Asabys invests in DeepUll extending its Series B to €17MAsabys announces today the first investment of its new fund, SAHII II (Sabadell Asabys Healthcare Innovation Investments II), launched with the support of Banco Sabadell, in DeepUll, a Barcelona-based disruptive medical diagnostics company developing culture-free, affordable diagnostic solutions for the early identification of sepsis and other ...
- Clara Campàs, PhD - Asabys PartnersManaging partner and co-founder of Asabys. Clara currently serves on the board of directors of Ona Therapeutics, Origo Biopharma, Sidekick Health, Nuage Therapeutics and Augustine Therapeutics.
- Home - Asabys PartnersAware of the importance of assuming full responsibility for its potential social and environmental impacts, Asabys is a pioneer firm in the life science venture capital industry obtaining the Sustainable Development Goals certification set by United Nations.
- Josep Ll. Sanfeliu - Asabys PartnersManaging partner, president and co-founder at Asabys. Josep currently serves on the board of directors of Anaconda, Cara Care, Inbrain Neuroelectronics, Medasense, Medlumics and Psious.
- TEAM - Asabys PartnersCookie Duration Description; cookielawinfo-checbox-analytics: 11 months: This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
More
